Volume 59, Issue 5, Pages (May 2001)

Slides:



Advertisements
Similar presentations
Volume 63, Issue 4, Pages (April 2003)
Advertisements

Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway  William A. Wilmer, Cynthia L. Dixon, Courtney Hebert 
Volume 56, Issue 5, Pages (November 1999)
Volume 59, Issue 5, Pages (May 2001)
Volume 59, Issue 5, Pages (May 2001)
G1 kinases and transforming growth factor-β; signaling are associated with a growth pattern switch in diabetes-induced renal growth  Hai-Chang Huang,
Volume 59, Issue 1, Pages (January 2001)
Volume 56, Issue 4, Pages (October 1999)
Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells  Hi Bahl.
Rapamycin is an effective inhibitor of human renal cancer metastasis1
Yihan Wang, Michael A. Shia, Thomas G. Christensen, Steven C. Borkan 
Volume 59, Issue 1, Pages (January 2001)
Volume 63, Issue 2, Pages (February 2003)
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Volume 67, Issue 5, Pages (May 2005)
Istvan Arany, Judit K. Megyesi, Jane E.B. Reusch, Robert L. Safirstein 
Volume 63, Issue 1, Pages (January 2003)
Volume 55, Issue 2, Pages (February 1999)
Volume 53, Issue 5, Pages (May 1998)
Volume 65, Issue 4, Pages (April 2004)
M.H.A. Baccora, P. Cortes, C. Hassett, D.W. Taube, J. Yee 
Volume 56, Issue 5, Pages (November 1999)
TGF-β isoforms in renal fibrogenesis
Volume 68, Issue 3, Pages (September 2005)
Volume 63, Issue 2, Pages (February 2003)
Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration  Brenda B. Hoffman, Kumar Sharma,
Volume 59, Issue 1, Pages (January 2001)
Volume 58, Issue 3, Pages (September 2000)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 56, Issue 4, Pages (October 1999)
Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells  Edward G. Lynn, Yaw L. Siow, Dr Karmin.
Volume 61, Issue 3, Pages (March 2002)
Volume 64, Issue 4, Pages (October 2003)
Volume 62, Issue 3, Pages (September 2002)
Volume 59, Issue 5, Pages (May 2001)
Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells1  Gunter Wolf, Regine Schroeder, Fuad N.
Volume 68, Issue 1, Pages (July 2005)
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Expression of inter-α-trypsin inhibitor and tumor necrosis factor-stimulated gene 6 in renal proximal tubular epithelial cells  Ulf Janssen, Gareth Thomas,
Volume 60, Issue 4, Pages (October 2001)
Volume 59, Issue 5, Pages (May 2001)
Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: Role of PI 3-kinase and ERK  Richard J. Dixon, Nigel J. Brunskill 
Volume 57, Issue 6, Pages (June 2000)
Volume 65, Issue 5, Pages (May 2004)
Volume 60, Issue 3, Pages (September 2001)
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy  Stuart Jones, Suzanne Jones, Aled Owain.
Hyaluronan increases glomerular cyclooxygenase-2 protein expression in a p38 MAP- kinase–dependent process  Marjorie E. Dunlop, Ph.D., Evelyne E. Muggli 
Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway  William A. Wilmer, Cynthia L. Dixon, Courtney Hebert 
Volume 62, Issue 1, Pages (July 2002)
Volume 53, Issue 6, Pages (June 1998)
Volume 61, Issue 5, Pages (May 2002)
Volume 116, Issue 6, Pages (June 1999)
Volume 58, Issue 1, Pages (July 2000)
Volume 69, Issue 1, Pages (January 2006)
Volume 70, Issue 6, Pages (September 2006)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 63, Issue 4, Pages (April 2003)
Volume 67, Issue 4, Pages (April 2005)
High glucose–induced PKC activation mediates TGF-β1 and fibronectin synthesis by peritoneal mesothelial cells  Hunjoo Ha, Mi Ra Yu, Hi Bahl Lee  Kidney.
Ho Jae Han, Soo Hyun Park, Hyun Ju Koh, Mary Taub  Kidney International 
Volume 60, Issue 3, Pages (September 2001)
Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa 
Volume 61, Issue 5, Pages (May 2002)
Lu-Cheng Cao, Thomas Honeyman, Julie Jonassen, Cheryl Scheid 
Volume 60, Issue 1, Pages (July 2001)
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 56, Issue 6, Pages (December 1999)
Differential effects of simvastatin on mesangial cells
Volume 62, Issue 3, Pages (September 2002)
TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers 
Presentation transcript:

Volume 59, Issue 5, Pages 1695-1705 (May 2001) High glucose inhibits renal proximal tubule cell proliferation and involves PKC, oxidative stress, and TGF-β1  Soo-Hyun Park, Hyun-Ju Choi, Jang-Hern Lee, Chang-Hoon Woo, Jae-Hong Kim, Ho-Jae Han  Kidney International  Volume 59, Issue 5, Pages 1695-1705 (May 2001) DOI: 10.1046/j.1523-1755.2001.0590051695.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 (A) Effects of time on 25mmol/L glucose-induced inhibition of [3H]-thymidine incorporation. When cultures were 70 to 80% confluent, proximal tubule cells (PTCs) were grown for different times (1 to 4 days) and pulsed with 1 μCi of [3H]-thymidine for 24 hours. (B) Dose-dependent effect of high glucose on [3H]-thymidine incorporation. When cultures were 70 to 80% confluent, PTCs were grown in the presence of various concentrations of glucose or mannitol for 72 hours and pulsed with 1 μCi of [3H]-thymidine for 24 hours. (C) Dose-dependent effect of high glucose on cell growth. Cells were cultured as described in this article without pulsing with [3H]-thymidine, and then cell counts were performed. Symbols are: (□) control; (▪) glucose; () mannitol. Values are means ± SE of three independent experiments with triplicate dishes. *P < 0.05 vs. control. Kidney International 2001 59, 1695-1705DOI: (10.1046/j.1523-1755.2001.0590051695.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Time-dependent effects of high glucose on [3H]-thymidine incorporation and cell growth. Cells were incubated in the presence of 5 (□) or 25 (▪) mmol/L glucose for 72 hours and subsequently pulsed with 1 μCi of [3H]-thymidine for 24 hours prior to count (A) or were cultured in medium containing 5 or 25mmol/L glucose, and then cell counts were performed at indicated days (B). Experiments were performed at days 5, 9, and 13, respectively. Values are means ± SE of three independent experiments with triplicate dishes. *P < 0.05 vs. each control. Kidney International 2001 59, 1695-1705DOI: (10.1046/j.1523-1755.2001.0590051695.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Distribution along the cell cycle of PTCs incubated with (A) 5 or (B) 25mmol/L glucose for 72 hours. The cell cycle stage was determined by flow cytometry. In A, G1 = 38.3%, S = 55.7%; G2 = 5.9%. In B, G1 = 54.5%, S = 44.1%; G2 = 1.4%. Group data and statistics are reported in Table 2. Kidney International 2001 59, 1695-1705DOI: (10.1046/j.1523-1755.2001.0590051695.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Dose-dependent effect of glucose on [3H]-leucine incorporation (A) and protein content (B). Cells were incubated for 72 hours in the presence of 10, 25, or 50mmol/L glucose and were subsequently pulsed with 2 μCi of [3H]-leucine for 24 hours. Values are means ± SE of four independent experiments with triplicate dishes. Symbols are: (□) 5mmol/L glucose; (▪) 25mmol/L glucose; *P < 0.05 vs. control. Kidney International 2001 59, 1695-1705DOI: (10.1046/j.1523-1755.2001.0590051695.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Dose-dependent effect of glucose on lipid peroxides (LPO) formation. PTCs were treated with 10, 25, or 50mmol/L glucose or mannitol for 72 hours. Values are means ± SE of four independent experiments with triplicate dishes. Symbols are: (□) control; (▪) glucose; () mannitol; *P < 0.05 vs. control. Kidney International 2001 59, 1695-1705DOI: (10.1046/j.1523-1755.2001.0590051695.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 6 Effects of antioxidants and hydrogen peroxide on 25mmol/L glucose-induced LPO formation (A) and [3H]-thymidine incorporation (B). PTCs were treated with taurine (2 mmol/L), N-acetylcystein (NAC; 10-5 mol/L), or vitamin E (VE; 10-5 mol/L) prior to the treatment of 25mmol/L glucose or were incubated with 25mmol/L glucose alone or together with hydrogen peroxide (10-7 mol/L) for 72 hours. Values are means ± SE of three or four independent experiments with triplicate dishes. Symbols are: (□) 5mmol/L glucose; (▪) 25mmol/L glucose; *P < 0.05 vs. control; **P < 0.05 vs. 25mmol/L glucose alone. Kidney International 2001 59, 1695-1705DOI: (10.1046/j.1523-1755.2001.0590051695.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 7 Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA), staurosporine, and H-7 on 25mmol/L glucose-induced [3H]-thymidine incorporation (A) and LPO formation (B). PTCs were treated with staurosporine (10-9 mol/L) or H-7 (10-7 mol/L) for 30 minutes prior to the treatment of 25mmol/L glucose or were incubated with 25mmol/L glucose alone or together with TPA (100 ng/mL) for 72 hours. Values are means ± SE of four independent experiments with triplicate dishes. Symbols are: (□) 5mmol/L glucose; (▪) 25mmol/L glucose; *P < 0.05 vs. control; **P < 0.05 vs. 25mmol/L glucose alone. Kidney International 2001 59, 1695-1705DOI: (10.1046/j.1523-1755.2001.0590051695.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 8 Effect of antioxidants on TPA-induced LPO formation. PTCs were treated with antioxidants (N-acetylcystein, vitamin E, taurine) prior to the treatment of TPA (100 ng/mL). Values are means ± SE of three independent experiments with triplicate dishes. Symbols are: (□) control; (▪) 100 ng/mL TPA; *P < 0.05 vs. control; **P < 0.05 vs. TPA alone. Kidney International 2001 59, 1695-1705DOI: (10.1046/j.1523-1755.2001.0590051695.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 9 Effect of 25mmol/L glucose on PKC translocation. PTCs were treated with 25mmol/L glucose for 72 hours. (A) The amount of PKC protein was determined by the immunoblot analysis of cytosolic (C) or particulate (P) fraction, as described in the Methods section. The arrow indicates the 80 kD band corresponding to PKC. The example shown is a representative of four experiments. (B) Data are expressed as a percentage of basal value in each fraction and is the means ± SE of four experiments. Symbols are: (□) 5mmol/L glucose; (▪) 25mmol/L glucose; *P < 0.05 vs. each control. Kidney International 2001 59, 1695-1705DOI: (10.1046/j.1523-1755.2001.0590051695.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 10 (A) Active TGF-β1 secretion by PTCs. PTCs were pretreated with staurosporine (10-9 mol/L) or taurine (2 mmol/L) for 30 minutes prior to the treatment of 25mmol/L glucose for 72 hours, and TGF-β1 was measured using enzyme-linked immunosorbent assay. Symbols are: (□) 5mmol/L glucose; (▪) 25mmol/L glucose; *P < 0.05 vs. 5mmol/L glucose; **P < 0.05 vs. 25mmol/L glucose. (B) The effect of TGF-β1 on [3H]-thymidine incorporation. PTCs were treated with a different dosage of TGF-β1 (0 to 10 ng/mL) for 72 hours and were subsequently pulsed with 1 μCi of [3H]-thymidine for 24 hours. Values are means ± SE of three independent experiments with triplicate dishes. *P < 0.05 vs. control. Kidney International 2001 59, 1695-1705DOI: (10.1046/j.1523-1755.2001.0590051695.x) Copyright © 2001 International Society of Nephrology Terms and Conditions